The Evidence Behind Extended-Infusion Piperacillin/Tazobactam


Are you aware that many bacteria are becoming increasingly resistant to current antimicrobial agents and this increase in resistance is outpacing discovery of novel antimicrobial agents? As a result, clinicians are challenged to make the best use of available antimicrobials to not only treat infections, but preserve the life-span of current agents.

In this webinar, Timothy Reilly, PharmD reviews:

  • The current status of multi-drug resistant bacteria
  • The pharmacokinetic and pharmacodynamic principles that govern extended infusions of beta lactam antibiotics
  • Available literature supporting the use of extended infusions of pipacillin/tazobactam
  • A community-based teaching hospital's experience with this treatment modality

To access the webinar, please fill out the form to the right.

Access the Webinar